HUTCHMED (China) (HCM) Change in Receivables (2020 - 2021)
HUTCHMED (China) (HCM) posted quarterly Change in Receivables of -$6.5 million for Q1 2021, down 480.47% year-over-year from $1.7 million in Q1 2020, and down 480.47% quarter-over-quarter from $1.7 million in Q1 2020.
HUTCHMED (China) (HCM) Change in Receivables (2020 - 2021) Analysis & Trends
HUTCHMED (China) (HCM) has reported Change in Receivables for 2 consecutive years, with -$6.5 million the latest figure, recorded in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 91.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 66.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -445.26 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | -1.70 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 126.50 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 84.30 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | HUTCHMED (China) | 2.19 Bn | 2.19 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | -6.53 Mn |
| Mar 31, 2021 | -6.53 Mn |
| Mar 31, 2020 | 1.72 Mn |
| Mar 31, 2020 | 1.72 Mn |